Tyvor Capital Decreased Its Autonation (AN) Stake; Harvard Bioscience (HBIO) Has 1.32 Sentiment

April 17, 2018 - By Vivian Park

AutoNation, Inc. (NYSE:AN) Logo

Tyvor Capital Llc decreased Autonation Inc (AN) stake by 66.33% reported in 2017Q4 SEC filing. Tyvor Capital Llc sold 250,228 shares as Autonation Inc (AN)’s stock declined 10.61%. The Tyvor Capital Llc holds 127,000 shares with $6.52M value, down from 377,228 last quarter. Autonation Inc now has $4.31 billion valuation. The stock increased 0.11% or $0.05 during the last trading session, reaching $46.94. About 141,046 shares traded. AutoNation, Inc. (NYSE:AN) has risen 8.96% since April 17, 2017 and is uptrending. It has underperformed by 2.59% the S&P500.

Harvard Bioscience Inc (HBIO) investors sentiment increased to 1.32 in 2017 Q4. It’s up 0.41, from 0.91 in 2017Q3. The ratio has improved, as 25 hedge funds opened new and increased equity positions, while 19 reduced and sold their equity positions in Harvard Bioscience Inc. The hedge funds in our database reported: 22.13 million shares, up from 21.49 million shares in 2017Q3. Also, the number of hedge funds holding Harvard Bioscience Inc in top ten equity positions was flat from 2 to 2 for the same number . Sold All: 3 Reduced: 16 Increased: 17 New Position: 8.

Glacier Peak Capital Llc holds 6.38% of its portfolio in Harvard Bioscience, Inc. for 1.33 million shares. First Light Asset Management Llc owns 4.64 million shares or 4.2% of their US portfolio. Moreover, Bard Associates Inc has 0.55% invested in the company for 347,372 shares. The Wisconsin-based Heartland Advisors Inc has invested 0.36% in the stock. Granahan Investment Management Inc Ma, a Massachusetts-based fund reported 935,717 shares.

Since January 1, 0001, it had 0 insider buys, and 3 sales for $1.00 million activity.

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company has market cap of $210.76 million. The firm offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, and isolated organ and tissue bath systems, as well as in vivo and in vitro electrophysiology recording, stimulation, and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It currently has negative earnings. It also provides products for molecular biology labs comprising pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables under the Denville Scientific and other brands.

The stock increased 1.19% or $0.0697 during the last trading session, reaching $5.9197. About 57,012 shares traded. Harvard Bioscience, Inc. (HBIO) has risen 87.27% since April 17, 2017 and is uptrending. It has outperformed by 75.72% the S&P500.

Analysts await Harvard Bioscience, Inc. (NASDAQ:HBIO) to report earnings on April, 26. HBIO’s profit will be $356,033 for 147.99 P/E if the $0.01 EPS becomes a reality. After $0.04 actual EPS reported by Harvard Bioscience, Inc. for the previous quarter, Wall Street now forecasts -75.00% negative EPS growth.

Since January 2, 2018, it had 0 insider purchases, and 3 insider sales for $1.09 million activity. The insider GRUSKY ROBERT R sold 5,000 shares worth $275,000.

Investors sentiment decreased to 0.79 in Q4 2017. Its down 0.09, from 0.88 in 2017Q3. It is negative, as 20 investors sold AN shares while 97 reduced holdings. 44 funds opened positions while 49 raised stakes. 62.82 million shares or 10.96% less from 70.55 million shares in 2017Q3 were reported. 52 are held by Huntington Bankshares. First Tru Advsrs Ltd Partnership reported 185,168 shares. Smith Graham Inv Advsrs LP invested in 95,528 shares or 0.46% of the stock. Geode Capital Mgmt Ltd Llc reported 504,692 shares. Louisiana State Employees Retirement Sys holds 0.03% or 15,000 shares in its portfolio. New Mexico Educational Retirement Board, New Mexico-based fund reported 14,700 shares. Riverhead Management Ltd holds 0.01% of its portfolio in AutoNation, Inc. (NYSE:AN) for 3,327 shares. Fmr Limited Liability Com has invested 0% in AutoNation, Inc. (NYSE:AN). State Treasurer State Of Michigan accumulated 0.01% or 21,300 shares. Public Employees Retirement Association Of Colorado invested in 8,793 shares. Utah Retirement holds 0.01% or 10,700 shares. Swiss Financial Bank reported 241,500 shares stake. Liberty Mutual Grp Inc Asset Mngmt owns 16,573 shares or 0.02% of their US portfolio. California State Teachers Retirement invested in 103,433 shares. Panagora Asset accumulated 7,545 shares or 0% of the stock.

Analysts await AutoNation, Inc. (NYSE:AN) to report earnings on May, 1 before the open. They expect $1.01 EPS, up 4.12% or $0.04 from last year’s $0.97 per share. AN’s profit will be $92.74 million for 11.62 P/E if the $1.01 EPS becomes a reality. After $1.02 actual EPS reported by AutoNation, Inc. for the previous quarter, Wall Street now forecasts -0.98% negative EPS growth.

Harvard Bioscience, Inc. (NASDAQ:HBIO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: